Search

everythinglearnresearchcommunity

for

Search:↓

Men with early hair loss may have a higher risk of enlarged prostate and possibly prostate cancer due to shared hormonal factors.

Finasteride for hair loss lowers PSA levels, so PSA values need adjusting when screening for prostate cancer.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Avicennia marina extract and avicequinone C can potentially promote hair growth and treat hair loss by interfering with hair loss mechanisms and boosting growth factors.

Dutasteride 0.5mg improves hair growth in 78% of people with hair loss, but may cause sexual problems in some.

Using your own platelet-rich plasma (PRP) can effectively treat hair loss, increasing hair density and width with no side effects.

Estradiol-rich plasma can increase hair density faster and more effectively in male pattern baldness treatment than regular plasma.

Photobiomodulation therapy significantly increases hair density and growth for androgenic alopecia, but more research is needed to confirm safety.

Hair loss can indicate brain aging and potential small vessel disease, but more research is needed to understand the clinical impact.

Hair loss in women may have multiple causes, and eyebrow regrowth possible with specific injections.

Chemotherapy-induced hair loss significantly affects patients' well-being, and nurses are key in helping them cope, but more research is needed to find effective treatments.

E211 G>A gene linked to lower risk of severe prostate cancer and hair loss.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

Spironolactone might help protect against severe lung problems in COVID-19 patients.

Using finasteride or dutasteride does not increase the risk of male breast cancer.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

Finasteride improves heart function and repairs damage after heart attack in mice.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

Some breast cancer patients on hormonal therapy may develop male or female pattern hair loss, which can sometimes be improved with topical treatments.

Finasteride helps reduce heart enlargement in heart failure patients.

Good nutrition is crucial for healthy hair and can help with hair loss without medication.

Eating a balanced diet with vitamins, micronutrients, and antioxidants is important for hair health and can help with hair loss.

Serum triglyceride levels are not linked to prostate cancer risk.

Flutamide rarely causes liver toxicity in prostate cancer patients.

Vertex pattern hair loss linked to higher prostate cancer risk.

Finasteride treats hair loss but may affect prostate cancer detection.

Some medications can improve skin conditions, while lifestyle factors like smoking and drinking may worsen them; treatments like monoclonal antibodies and imiquimod cream show promise for certain skin diseases.

Short-term finasteride treatment may lower some cell death factors in prostate cancer cells.

The trial will test if YH0618 granule prevents hair loss in breast cancer patients during chemotherapy.

IGRT resulted in lower acute toxicity for stage III prostate cancer patients.